We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dense Cervical Allograft Promotes Speedy Healing

By HospiMedica staff writers
Posted on 29 May 2007
A corticocancellous allograft provides structural integrity and dense cancellous bone to allow immediate perfusion and rapid healing.

The Connect II cervical structural allograft is produced from dense cancellous bone with a thick anterior cortical face to maximize compressive strength for optimal fusion. More...
The allograft is machined from the femoral head and other non-vertebral bone sources, and the fresh-frozen implant ensures optimal mechanical strength. Rapid perfusion and the cancellous matrix provide the structural and biologic conditions necessary for optimal healing.

The dimensions of allograft are 14 mm in width, 14 mm in length, and the heights vary from 5-10 mm. All Connect II product sizes utilize a 7° lordotic angulation that re-establishes sagittal alignment and provides for maximum graft-to-host bone surface area. The range of sizes and design provides optimal distraction, and permits customization to various patient specific needs, while the large graft-to-host bone surface contact area promotes excellent healing ability.

The Connect II cervical structural allograft spacer is manufactured by Alphatec (Carlsbad, CA, USA), and comes with proprietary cervical fusion instrumentation for maximum ease of use, procedural efficiency, and conformity with other products in the Alphatec cervical fusion product line.

"Allografts have a very strong following in the surgeon community due to their high success rates and ease of use, and our Connect II product provides an excellent matrix for rapid perfusion leading to successful patient outcomes, and we believe that it will become the allograft of choice for many surgeons,” said M. Ross Simmonds, senior vice president and chief operating officer (COO) of Alphatec.


Related Links:
Alphatec

Gold Member
12-Channel ECG
CM1200B
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Wound Irrigation Solution
Prontosan®
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.